Artio closes $28M as it scales to save lives; latest funding brings Prairie Village startup’s investments to $74M
June 16, 2022 | Startland News Staff
Another hefty funding round for Artio Medical is expected to launch the startup’s commercial sales team in the U.S. and continue development of its best-in-class product pipeline, said founder Nicholas Franano.
Artio, a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, on Thursday announced the closing of $28 million in oversubscribed Series A2 and Series A3 financing, bringing the total amount raised to date to $74 million.
Funds will be used to support U.S. commercialization efforts for the recently cleared Solus Gold Embolization Device and to accelerate the development of Artio’s broad portfolio of products, including expanding the company’s engineering and manufacturing capabilities, Franano said in a press release.
Click here to read more about Artio’s $12 million funding infusion in 2021.
“We would like to thank our existing investors for their continued strong support and also welcome a new group of investors to Artio,” said Joseph McConnell, vice president of finance and business operations at Artio.
“We have the opportunity to do something really special here, to bring a new generation of medical devices to market with the potential to save lives, reduce disability, and improve the quality of life for millions of people,” McConnell continued. “This new capital will help Artio expand our team and scale our operations to deliver on that mission.”
Artio is currently developing ten products for the peripheral vascular market, including the Solus Gold and Solus Flex Embolization Devices for peripheral vessel occlusion and the Amplifi Vein Dilation System which is designed to prepare hemodialysis patients for successful arteriovenous fistula vascular access site creation.
Artio is also currently developing four products for the neurovascular market, including the Endura Embolization System comprising a detachable balloon and coils for the treatment of saccular brain aneurysms.
Click here to learn more about Artio’s portfolio of products.
2022 Startups to Watch
stats here
Related Posts on Startland News
KCSF pivoting away from Village Square coworking, eyes bigger community impact
Village Square developed a waiting list soon after opening in 2015, said Adam Arredondo. But as larger coworking spaces with more amenities and resources debuted, interest waned in the 3,000-square-foot operation at 45th Street and State Line Road. “What’s our most valuable contribution to the community right now?” said Arredondo, CEO of the nonprofit Kansas…
Beyond KC: TripSushi puts secret hotspots, meaningful travel experiences on the menu
Life is short, said Spencer Carlson — you have just one chance to knock out as much on your to-do list as possible. For the founder of TripSushi, a KC-based travel agency, that meant soaking in and connecting to peoples and locales across the globe, he said. “[We] need to experience other cultures so that…
Eastside Collaborative coworking space envisions a home for black entrepreneurs
Stay on the lookout for Eastside Collaborative, said Maleika Robinson. Recognizing a need for a coworking space specifically for black entrepreneurs, Robinson founded Eastside Collaborative in early 2018 after rebranding the KC Black Coworking Community. Eastside operates from within Uzazi Village on Tuesdays and creates an environment where she and others can be their authentic…
1 Million Cups KC move to Plexpod Westport Commons percolating
1 Million Cups — Kansas City’s most-popular entrepreneur event series — is brewing a move to the area’s largest coworking community. After six years of hosting the entrepreneurial showcase event at the Ewing Marion Kauffman Foundation, 1MCKC is moving its weekly program to Plexpod Westport Commons. 1 Million Cups began in Kansas City in April…